Article:
Updates on pharmacological treatment of post-traumatic stress disorder

creativeworkseries.issnJNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X
dc.contributor.authorKoirala, Rishav
dc.contributor.authorSaegaard, Erik Ganesh Iyer
dc.contributor.authorThapa, Suraj Bahadur
dc.creator.affiliationInstitute of Clinical Medicine, Faculty of Medicine,University of Oslo ; Psycho-oncology Clinic, Nepal Cancer Hospital and Research Center, Harisiddhi, Lalitpur, Nepal.
dc.creator.affiliationInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo; Division of Mental Health and Addiction, Oslo University Hospital.
dc.creator.affiliationInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo; Division of Mental, Health and Addiction, Oslo University Hospital, Oslo.
dc.date.accessioned2026-09-21T08:01:24Z
dc.date.available2026-09-21T08:01:24Z
dc.date.issued2017
dc.description.abstractAbstract Post-Traumatic Stress Disorder affects a significant proportion of those who have been exposed to exceptionally threatening or catastrophic events or situations such as earthquakes, rape and civil war. The condition can often become chronic and disabling. Medical intervention can therefore be of paramount importance. There are no national guidelines for trauma disorders in Nepal and there is a lack of adequate knowledge regarding drug treatment of PTSD among doctors and other service providers. Though psychotherapy is internationally regarded as the first line treatment for PTSD, it is often not feasible in Nepal due to lack of resources and skilled health workers in this field. The use of right psycho-pharmacotherapy is therefore important to reduce the burden of disease. A wide range of pharmacotherapy has been tested in the treatment of PTSD. This article is based on a selected sample of relevant articles from PubMed, PsycINFO, national guidelines from other countries and our own clinical experience. We have tried to give a concise and practical review regarding the use of drugs, their side effects and available evidence in the treatment of PTSD. The main findings point to use of Selective Serotonin Reuptake Inhibitors as the first line pharmacotherapy, and they can have effect on the full range of symptoms in PTSD. SNRIs show similar efficacy. Adjuvant drugs like Alpha-blockers and atypical antipsychotics have shown strong evidence in treating partially remitted cases and resolving ancillary symptoms. Keywords: Antidepressive Agents; Drug Therapy; Post-Traumatic; Psychotropic Drugs; Stress Disorder.
dc.identifier.doihttps://doi.org/10.31729/jnma.3108
dc.identifier.urihttps://hdl.handle.net/20.500.14572/7783
dc.language.isoen_US
dc.publisherNepal Medical Association
dc.subjectAntidepressive Agents
dc.subjectDrug Therapy
dc.subjectPost-Traumatic
dc.subjectPsychotropic Drugs
dc.subjectStress Disorder
dc.titleUpdates on pharmacological treatment of post-traumatic stress disorder
dc.typeArticle
dspace.entity.typePublication
local.article.typeReview Article
oaire.citation.endPage280
oaire.citation.startPage274
relation.isJournalIssueOfPublication67f4f287-6893-47e1-b45e-2cf1554665ce
relation.isJournalIssueOfPublication.latestForDiscovery67f4f287-6893-47e1-b45e-2cf1554665ce
relation.isJournalOfPublicatione6e146a0-0ece-4aba-aa0a-6ccfbd10a12a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
274-280.pdf
Size:
546.94 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections